Sarcoidosis and tuberculosis (TB) are both granulomatous diseases, but their immune mechanisms differ. Sarcoidosis is characterized by clusters of immune cells called granulomas, while TB is caused by Mycobacterium tuberculosis. Both diseases involve granuloma formation, but the immune processes differ. In TB, granulomas are formed in response to M. tuberculosis, while in sarcoidosis, the cause is less clear, possibly involving a variety of antigens. The immune response in TB is dominated by Th1 cells, while in sarcoidosis, Th1 and Th17 cells are involved. Granuloma formation in TB is driven by the immune system's response to M. tuberculosis, while in sarcoidosis, it may be driven by genetic factors and diverse antigens. The immune cells involved in granuloma formation include macrophages, T cells, and monocytes. In TB, macrophages are the first to encounter M. tuberculosis, while in sarcoidosis, the immune response is more complex. The role of mTORC1 signaling in granuloma formation is important in both diseases, but the cause of its activation differs. In TB, mTORC1 is activated by the pathogen, while in sarcoidosis, it may be due to genetic mutations. The immune response in TB is more controlled, while in sarcoidosis, it may be more dysregulated. The presence of Tregs and the role of Th17 cells in granuloma formation are also important in both diseases. Single-cell analysis has provided new insights into the immune mechanisms of granuloma formation in both diseases, highlighting the differences in immune cell composition and function. Overall, the immune mechanisms of granuloma formation in sarcoidosis and TB are complex and involve a variety of immune cells and pathways.Sarcoidosis and tuberculosis (TB) are both granulomatous diseases, but their immune mechanisms differ. Sarcoidosis is characterized by clusters of immune cells called granulomas, while TB is caused by Mycobacterium tuberculosis. Both diseases involve granuloma formation, but the immune processes differ. In TB, granulomas are formed in response to M. tuberculosis, while in sarcoidosis, the cause is less clear, possibly involving a variety of antigens. The immune response in TB is dominated by Th1 cells, while in sarcoidosis, Th1 and Th17 cells are involved. Granuloma formation in TB is driven by the immune system's response to M. tuberculosis, while in sarcoidosis, it may be driven by genetic factors and diverse antigens. The immune cells involved in granuloma formation include macrophages, T cells, and monocytes. In TB, macrophages are the first to encounter M. tuberculosis, while in sarcoidosis, the immune response is more complex. The role of mTORC1 signaling in granuloma formation is important in both diseases, but the cause of its activation differs. In TB, mTORC1 is activated by the pathogen, while in sarcoidosis, it may be due to genetic mutations. The immune response in TB is more controlled, while in sarcoidosis, it may be more dysregulated. The presence of Tregs and the role of Th17 cells in granuloma formation are also important in both diseases. Single-cell analysis has provided new insights into the immune mechanisms of granuloma formation in both diseases, highlighting the differences in immune cell composition and function. Overall, the immune mechanisms of granuloma formation in sarcoidosis and TB are complex and involve a variety of immune cells and pathways.